scholarly journals Angiostrongylus cantonensis: a review of its distribution, molecular biology and clinical significance as a human pathogen – CORRIGENDUM

Parasitology ◽  
2019 ◽  
Vol 146 (10) ◽  
pp. 1360-1360 ◽  
Author(s):  
Joel LN Barratt ◽  
John Ellis
2011 ◽  
Vol 60 (3) ◽  
pp. 375-377 ◽  
Author(s):  
Rodrigo Cayô ◽  
Lucrecia Yañez San Segundo ◽  
Inmaculada Concepción Pérez del Molino Bernal ◽  
Celia García de la Fuente ◽  
Maria Aranzazu Bermúdez Rodríguez ◽  
...  

Acinetobacter junii is a rare human pathogen associated with bacteraemia in neonates and paediatric oncology patients. We present a case of A. junii causing bacteraemia in an adult transplant patient with leukaemia. The correct identification of Acinetobacter species can highlight the clinical significance of the different species of this genus.


2009 ◽  
Vol 10 (1) ◽  
pp. 97 ◽  
Author(s):  
Hualiang He ◽  
Mei Cheng ◽  
Xiao Yang ◽  
Jinxiu Meng ◽  
Ai He ◽  
...  

Parasitology ◽  
2016 ◽  
Vol 143 (9) ◽  
pp. 1087-1118 ◽  
Author(s):  
JOEL BARRATT ◽  
DOUGLAS CHAN ◽  
INDY SANDARADURA ◽  
RICHARD MALIK ◽  
DEREK SPIELMAN ◽  
...  

SUMMARYAngiostrongylus cantonensisis a metastrongyloid nematode found widely in the Asia-Pacific region, and the aetiological agent of angiostrongyliasis; a disease characterized by eosinophilic meningitis.Rattusrats are definitive hosts ofA. cantonensis, while intermediate hosts include terrestrial and aquatic molluscs. Humans are dead-end hosts that usually become infected upon ingestion of infected molluscs. A presumptive diagnosis is often made based on clinical features, a history of mollusc consumption, eosinophilic pleocytosis in cerebral spinal fluid, and advanced imaging such as computed tomography. Serological tests are available for angiostrongyliasis, though many tests are still under development. While there is no treatment consensus, therapy often includes a combination of anthelmintics and corticosteroids. Angiostrongyliasis is relatively rare, but is often associated with morbidity and sometimes mortality. Recent reports suggest the parasites’ range is increasing, leading to fatalities in regions previously consideredAngiostrongylus-free, and sometimes, delayed diagnosis in newly invaded regions. Increased awareness of angiostrongyliasis would facilitate rapid diagnosis and improved clinical outcomes. This paper summarizes knowledge on the parasites’ life cycle, clinical aspects and epidemiology. The molecular biology ofAngiostrongylusspp. is also discussed. Attention is paid to the significance of angiostrongyliasis in Australia, given the recent severe cases reported from the Sydney region.


Sign in / Sign up

Export Citation Format

Share Document